EPIDEMIOLOGIC AND GENETIC STUDIES OF BREAST CANCER
乳腺癌的流行病学和遗传学研究
基本信息
- 批准号:2096860
- 负责人:
- 金额:$ 74.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-03-13 至 1996-12-31
- 项目状态:已结题
- 来源:
- 关键词:breast neoplasm /cancer diagnosis breast neoplasms cancer risk case history death certificates environment related neoplasm /cancer family genetics female gene expression genetic polymorphism health surveys human morbidity human mortality human subject interview linkage mapping longitudinal human study mammography neoplasm /cancer epidemiology neoplasm /cancer genetics pathology phenotype questionnaires statistics /biometry
项目摘要
The known risk factors for breast cancer - environmental, behavioral and
genetic - account only for about 25% of the variability in incidence.
Investigations of the interplay of genes and environment are needed to
elucidate the pathogenesis of the disease. The purpose of the proposed
research is to 1) determine the morbidity and mortality status of an
established cohort of first- and second-degree female relatives (sisters,
daughters, nieces, granddaughters) of a group of breast cancer probands
originally studied at the University of Minnesota between 1944 and 1952; 2)
to examine how epidemiologic risk factors influence lifetime cumulative
risk by performing segregation analyses that incorporate
environmental/behavioral covariates (including parenchymal pattern) using
breast cancer and some or all subtypes of benign breast disease as
phenotypes; 3) to explore the genetic heterogeneity of breast cancer in
subsets of families defined by both the types of malignancies observed and
histologic type of the proband (determined by a review of the pathology
slides from the original cohort); 4) to perform genetic linkage analyses on
a subset of informative families using a candidate gene approach to confirm
the existence of a susceptibility gene(s).
Detailed, documented histories of breast and other cancers are known for
both maternal and paternal blood lines. These data are noteworthy for
several reasons: 1) the sampling scheme at baseline was population-based
and is easily allowed for in the analyses; 2) the number of generations
with complete cancer histories minimizes the uncertainty of inherited
susceptibility to diseases with variable age at onset; 3) the large number
of families permits exploration of genetic heterogeneity of breast cancer
and minimizes the misclassification of families as sporadic, familial or
hereditary; and 4) a number of medical history/reproductive risk factors
were collected on these relatives at baseline. Using established tracking
procedures, we will update the vital status of family members and extend
the pedigrees to include grandchildren. We have already successfully
located at least one family member in all of the families selected for the
pilot study. Questionnaire data, mammographies and blood samples will be
obtained. Outcomes of the analysis will include a quantitative risk of
breast cancer attributable to a family history; information on the pattern
of inheritance of susceptibility to breast and other cancers; and evidence
to support the physical location of a susceptibility gene(s).
The proposed project will provide valuable information on the genetic
epidemiology of breast cancer vital to primary prevention of the disease.
乳腺癌的已知危险因素 - 环境,行为和
遗传 - 仅占发病率变异性的25%。
需要对基因与环境的相互作用进行调查
阐明该疾病的发病机理。 提议的目的
研究是1)确定一个
建立的一级和二级女性亲戚(姐妹,
一组乳腺癌概率的女儿,侄女,孙女)
最初在1944年至1952年之间在明尼苏达大学学习; 2)
检查流行病学风险因素如何影响终生累积
通过进行隔离分析来冒险
使用环境/行为协变量(包括实质模式)
乳腺癌和良性乳房疾病的某些或所有亚型
表型; 3)探索乳腺癌的遗传异质性
两种观察到的恶性肿瘤类型定义的家庭子集和
概率的组织学类型(由病理学的综述确定
原始队列的幻灯片); 4)对
使用候选基因方法确认的一部分信息家庭
易感基因的存在。
详细的,有记录的乳房和其他癌症的历史
母亲和父亲的血管。 这些数据值得注意
几个原因:1)基线的抽样方案是基于人群的
并很容易进行分析; 2)世代的数量
完整的癌症历史可以最大程度地减少遗传的不确定性
发作时年龄变化的疾病的敏感性; 3)大量
家庭允许探索乳腺癌的遗传异质性
并最大程度地减少对家庭的错误分类为零星,家族或
遗传; 4)许多病史/生殖风险因素
在基线上收集在这些亲戚上。 使用已建立的跟踪
程序,我们将更新家庭成员的生命状况并扩展
谱系包括孙子。 我们已经成功
在所有被选中的家庭中至少一个家庭成员
试点研究。 问卷数据,乳房X线和血液样本将是
获得。 分析结果将包括定量风险
乳腺癌归因于家族史;有关模式的信息
对乳房和其他癌症的易感性的遗传;和证据
支持易感基因的物理位置。
拟议的项目将提供有关遗传的有价值的信息
乳腺癌的流行病学对疾病初级预防至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS A SELLERS其他文献
THOMAS A SELLERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS A SELLERS', 18)}}的其他基金
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
卵巢癌遗传关联和相互作用研究 (FOCI) 的随访
- 批准号:
8504772 - 财政年份:2010
- 资助金额:
$ 74.42万 - 项目类别:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
卵巢癌遗传关联和相互作用研究 (FOCI) 的随访
- 批准号:
8871955 - 财政年份:2010
- 资助金额:
$ 74.42万 - 项目类别:
Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)
卵巢癌遗传关联和相互作用研究 (FOCI) 的随访
- 批准号:
8104223 - 财政年份:2010
- 资助金额:
$ 74.42万 - 项目类别:
相似国自然基金
解毒三根汤基于β-catenin/ZEB1逆转AKT抑制剂诱导AKT1 E17K突变乳腺癌EMT的协同增效机制研究
- 批准号:82305336
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于磁共振APT成像的乳腺癌新辅助治疗敏感性预测研究
- 批准号:82302153
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
海洋来源二倍半萜MHO7靶向整合素β8/TGF-β轴调控EMT抑制三阴性乳腺癌转移的作用机制研究
- 批准号:82304550
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGK3/BECN1信号促进自噬介导乳腺癌对他莫昔芬耐药机制研究
- 批准号:82373901
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
调控线粒体钙失稳纳米信使联合自噬抑制用于乳腺癌的信号级联可视化治疗研究
- 批准号:82302210
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis
恶变前乳腺组织环境中肠道微生物介导的差异增强了早期乳腺肿瘤转移
- 批准号:
10594667 - 财政年份:2023
- 资助金额:
$ 74.42万 - 项目类别:
Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities
阐明与多发性骨髓瘤风险差异相关的新型表观遗传修饰
- 批准号:
10912191 - 财政年份:2023
- 资助金额:
$ 74.42万 - 项目类别:
Hawaii Pacific Islands Mammography Registry
夏威夷太平洋岛屿乳腺X线摄影登记处
- 批准号:
10819068 - 财政年份:2023
- 资助金额:
$ 74.42万 - 项目类别:
Improving our understanding of breast cancer mortality disparities through recurrence: a multi-level approach among women in Georgia
通过复发提高我们对乳腺癌死亡率差异的理解:格鲁吉亚妇女的多层次方法
- 批准号:
10818726 - 财政年份:2023
- 资助金额:
$ 74.42万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 74.42万 - 项目类别: